Delcath Systems, Inc. (DCTH)
19.70
+0.33
(+1.70%)
USD |
NASDAQ |
Nov 18, 16:00
19.70
0.00 (0.00%)
After-Hours: 20:00
Delcath Systems Enterprise Value : 583.09M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 583.09M |
| November 17, 2026 | 571.61M |
| November 16, 2026 | 589.00M |
| November 13, 2026 | 612.64M |
| November 12, 2026 | 641.50M |
| November 11, 2026 | 655.06M |
| November 10, 2026 | 596.99M |
| November 09, 2026 | 602.91M |
| November 06, 2026 | 417.23M |
| November 05, 2026 | 401.93M |
| November 04, 2026 | 413.40M |
| November 03, 2026 | 398.80M |
| November 02, 2026 | 394.97M |
| October 30, 2026 | 386.28M |
| October 29, 2026 | 407.14M |
| October 28, 2026 | 414.79M |
| October 27, 2026 | 410.97M |
| October 26, 2026 | 402.62M |
| October 23, 2026 | 399.49M |
| October 22, 2026 | 410.97M |
| October 21, 2026 | 409.23M |
| October 20, 2026 | 411.32M |
| October 19, 2026 | 397.76M |
| October 16, 2026 | 387.67M |
| October 15, 2026 | 413.05M |
| Date | Value |
|---|---|
| October 14, 2026 | 409.93M |
| October 13, 2026 | 430.79M |
| October 12, 2026 | 442.96M |
| October 09, 2026 | 432.18M |
| October 08, 2026 | 421.05M |
| October 07, 2026 | 432.87M |
| October 06, 2026 | 433.92M |
| October 05, 2026 | 449.91M |
| October 02, 2026 | 424.18M |
| October 01, 2026 | 433.92M |
| September 30, 2026 | 453.39M |
| September 29, 2026 | 455.55M |
| September 28, 2026 | 454.16M |
| September 25, 2026 | 446.89M |
| September 24, 2026 | 463.51M |
| September 23, 2026 | 459.36M |
| September 22, 2026 | 474.60M |
| September 21, 2026 | 464.55M |
| September 18, 2026 | 464.55M |
| September 17, 2026 | 469.40M |
| September 16, 2026 | 468.36M |
| September 15, 2026 | 466.63M |
| September 14, 2026 | 475.98M |
| September 11, 2026 | 457.62M |
| September 10, 2026 | 453.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 208.41B |
| AngioDynamics, Inc. | 457.01M |
| Alphatec Holdings, Inc. | 1.621B |
| AtriCure, Inc. | 2.733B |
| Baxter International, Inc. | 19.54B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.952M |
| Revenue (Quarterly) | 35.10M |
| Total Expenses (Quarterly) | 28.15M |
| EPS Diluted (Quarterly) | 0.1695 |
| Gross Profit Margin (Quarterly) | 88.84% |
| Profit Margin (Quarterly) | 19.81% |
| Earnings Yield | 0.79% |
| Operating Earnings Yield | 0.75% |
| Normalized Earnings Yield | 0.7863 |